INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | -94.3% | 11,490 | -88.3% | 0.00% | -100.0% |
| Q1 2022 | $353,000 | +6.3% | 98,400 | +48.0% | 0.00% | 0.0% |
| Q4 2021 | $332,000 | -23.5% | 66,500 | +9.7% | 0.00% | -50.0% |
| Q3 2021 | $434,000 | -8.8% | 60,600 | +18.1% | 0.00% | 0.0% |
| Q2 2021 | $476,000 | +228.3% | 51,303 | +310.4% | 0.00% | +100.0% |
| Q3 2020 | $145,000 | +88.3% | 12,500 | +9.6% | 0.00% | 0.0% |
| Q4 2015 | $77,000 | +352.9% | 11,400 | +280.0% | 0.00% | – |
| Q3 2015 | $17,000 | +466.7% | 3,000 | +650.0% | 0.00% | – |
| Q2 2015 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
| Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
| Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
| Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
| WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
| EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
| Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
| Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |